SDHB mutations are known to be highly penetrant, with lifetime risk of PGL/PCC as high as 77–100% and lifetime risk of renal cell carcinoma estimated to be 10–20% [35]. This evidence concerns the gene SDHB and adrenal gland pheochromocytoma.